Search results for: Multi-Indication Medicines
Filter search results
The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?
1 February 2012
…costs and challenges. As a result, the overall balance remains unclear, despite strong opinions regarding one specific scheme (the UK’s risk sharing scheme for multiple sclerosis drugs). They find that…
Achieving World Class Outcomes in Cancer Treatment
1 July 2011
…use of multidisciplinary treatment approaches. He sees considerable opportunity for improvement in the proportion of patients receiving curative treatments, the use of palliative treatment (particularly chemotherapy), and one-year survival rates….
The Ideas and Influence of Alan Williams: Be Reasonable – Do It My Way
1 February 2008
…even across multiple sectors. Alan vigorously contested charges that cost–benefit analysis was a “pseudo-science”. However, modern economic evaluation is not immune to the same allegations. Peggy and Richard Musgrave, who…
Physical Impairment: Social Handicap
1 November 1977
…arthritis may need help very different from that required by individuals with epilepsy, multiple sclerosis, chronic bronchitis, a spinal injury, blindness1 or a combination of such afflictions. And factors such…
Osteoporosis and the risk of fracture
1 January 1990
…that osteoporosis and its related fractures are a multidisciplinary problem, that is it crosses several specialities in medicine including orthopaedics, geriatrics and gynaecology. The most obvious manifestation of osteoporosis is…
Disease Management, the NHS and the Pharmaceutical Industry
1 March 1999
Share this: Download publication Anne R. Mason Michael F. Drummond Adrian Towse Disease management is a term with multiple and ambiguous meanings. For some, it is purely a form of…
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
…in unregulated or less regulated markets, compared to strictly regulated markets. Second, regulation clearly undermines competition in the off-patent, multisource sector, which is contrary to sound economics and to the…
Don’t Look Back? Voluntary and Charitable Finance of Hospitals
1 July 2001
…to private payment and a shift to mass contributory arrangements. However, the late 1930s saw financial crisis looming, as current account deficits multiplied and the asset base of many institutions…
Pharmaceuticals in Developing Countries 1981-82
1 July 1984
…survey are listed in Appendix I. It is clear from the study that the multi-national research-based pharmaceutical companies based in Western Europe are making a considerable contribution to health care…